Progress in the tissue engineering and stem cell industry "are we there yet?"

Tissue Engineering - Part B: Reviews

Volumn 18, Issue 3, 2012, Pages 155-166

  Jaklenec, Ana ^a   Stamp, Andrea ^b   Deweerd, Elizabeth ^c   Sherwin, Angela ^d,e   Langer, Robert ^a  

^a Massachusetts Institute of Technology   (United States)

^b Mass MEDIC   (United States)

^c NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^d BROWN UNIVERSITY   (United States)

^e Office of the Health Insurance Commissioner State of Rhode Island   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDUSTRY; SALES; TISSUE ENGINEERING;

STEM CELLS;

BIOMATERIAL; WOUND HEALING PROMOTING AGENT;

COMMERCIAL PHENOMENA; EMPLOYEE; FOOD AND DRUG ADMINISTRATION; INDUSTRY; MARKETING; ORTHOPEDICS; PERSONNEL MANAGEMENT; PRIORITY JOURNAL; PROFIT; REGENERATIVE MEDICINE; REVIEW; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; UNITED STATES; WOUND HEALING;

COMMERCE; DRUG INDUSTRY; GEOGRAPHY; HUMANS; STEM CELL RESEARCH; STEM CELLS; TISSUE ENGINEERING;

EID: 84860623107     PISSN: 19373368     EISSN: 19373376     Source Type: Journal    
DOI: 10.1089/ten.teb.2011.0553     Document Type: Review

References (18)

1. Lysaght, M.J., and Reyes, J. The growth of tissue engineering. Tissue Eng 7, 485, 2001.
2. Lysaght, M.J., and O'Loughlin, J.A. Demographic scope and economic magnitude of contemporary organ replacement therapies. Asaio J 46, 515, 2000.
3. Lysaght, M.J., Jaklenec, A., and Deweerd, E. Great expectations: private sector activity in tissue engineering, regenerative medicine, and stem cell therapeutics. Tissue Eng Part A 14, 305, 2008.
4. Lysaght, M.J., and Hazlehurst, A.L. Tissue engineering: the end of the beginning. Tissue Eng 10, 309, 2004.
5. Lysaght, M.J. Product development in tissue engineering. Tissue Eng 1, 221, 1995.
6. Nerem, R.M. Regenerative medicine: the emergence of an industry. J R Soc Interface 7 Suppl 6, S771, 2010.
7. Gillian, M. Body Doubles. Good Morning America. April 29, 1999.
8. Nahmias, Y., and Yarmush, M. Tissue engineering application in general surgery. In: Meyer, U., Meyer, T., Handschel, J., and Wiesmann, H.P., eds. Fundamentals of Tissue Engineering and Regenerative Medicine (1st edition). Berlin: Springer, 2009.
9. Langer, R., and Vacanti, J.P. Tissue engineering. Science 260, 920, 1993.
10. Mason, C., Brindley, D.A., Culme-Seymour, E.J., and Davie, N.L. Cell therapy industry: billion dollar global business with unlimited potential. Regen Med 6, 265, 2011.
11. Mason, C., and Manzotti, E. Regenerative medicine cell therapies: numbers of units manufactured and patients treated between 1988 and 2010. Regen Med 5, 307, 2010.
12. Martin, P.H., Hawksley, R., and Turner, A. The Commercial Development of Cell Therapy-Lessons for the Future? Nottingham, UK: Institute for Science and Society, University of Nottingham, 2009.
13. Carragee, E.J., Ghanayem, A.J., Weiner, B.K., Rothman, D.J., and Bono, C.M. A challenge to integrity in spine publications: years of living dangerously with the promotion of bone growth factors. Spine J 11, 463, 2011.
14. Lee, M.H., Arcidiacono, J.A., Bilek, A.M., Wille, J.J., Hamill, C.A., Wonnacott, K.M., et al. Considerations for tissueengineered and regenerative medicine product development prior to clinical trials in the United States. Tissue Eng Part B Rev 16, 41, 2009.
15. Johnson, P.C., Bertram, T.A., Tawil, B., and Hellman, K.B. Hurdles in tissue engineering/regenerative medicine product commercialization: a survey of North American academia and industry. Tissue Eng Part A 17, 5, 2011.
16. Barker, C., Culme-Seymour, E., Dalton, S., Hayek, A., and Genbacev, O. The year in regenerative medicine. Regen Med 6, 21, 2011.
17. ACT Announces First Patients Undergo Embryonic Stem Cell Transplantation Treatment for Stargardt's Disease and Macular Degeneration at UCLA's Jules Stein Eye Institute. Advanced Cell Technology, 2011. http://www.advancedcell .c om/news-and-media/press-releases/act-announces-firstpatients-undergo-embryonic- stem-cell-transplantation-treatmentfor-stargardts-disease-and-macular-dege neration-at-uclas-julesstein-eye-institute/index.asp
18. Ginty, P.J., Singh, P.B., Smith, D., Hourd, P., and Williams, D.J. Achieving reimbursement for regenerative medicine products in the USA. Regen Med 5, 463, 2010.